McDougle C. J. et al. (2000)
Child and Adolescent Psychiatric Clinics of North America
January, 9(1), pp. 201-224.
McDougle C. J. , Stigler K. A. , Posey D. J. (2003)
Treatment of aggression in children and adolescents with autism and conduct disorder.
Journal of Clinical Psychiatry
64 pp. 16-25
Nikolov R. N. et al. (2009)
Gastrointestinal symptoms in a sample of children with pervasive developmental disorders.
Journal of Autism and Developmental Disorders
39(3), pp. 405-413
Posey D. J. et al. (2004)
A pilot study of D-cycloserine in subjects with autistic disorder.
American Journal of Psychiatry
161(11), pp. :2115-2117
Posey D. J. et al. (2008)
Antipsychotics in the treatment of autism.
Journal of Clinical Investigation
118(1), pp. 6-14
Posey D. J. , Erickson C. A. , McDougle C. J. (2008)
Developing drugs for core social and communication impairment in autism.
Child and Adolescent Psychiatric Clinics of North America
17(4), pp. 787-801
Posey D. J. , McDougle C. J. (2001)
Pharmacotherapeutic management of autism.
Expert Opinion on Pharmacotherapy
2(4), pp. 587-600
Posey D. J. et al. (1999)
Risperidone in the treatment of two very young children with autism.
Journal of Child and Adolescent Psychopharmacology
9(4), pp. 273-276
Posey D. J. et al. (2006)
The use of selective serotonin reuptake inhibitors in autism and related disorders.
Journal of Child and Adolescent Psychopharmacology
16(1), pp. 181-186
Scahill L. et al. (2006)
A prospective open trial of guanfacine in children with pervasive developmental disorders.
Journal of Child and Adolescent Psychopharmacology
16(5), pp. 589-598.
Scahill L. et al. (2001)
Journal of Child and Adolescent Psychopharmacology
Winter, 11(4), pp, 377-88.
Stigler K. A. et al. (2004)
A naturalistic retrospective analysis of psychostimulants in pervasive developmental disorders.
Journal of Child and Adolescent Psychopharmacology
14(1), pp. 49-56
Stigler K. A. et al. (2009)
Autism and immune factors: A comprehensive review.
Research in Autism Spectrum Disorders
pp. 840-860